Tevogen Bio Holdings Inc. — Institutional Ownership
Which tracked institutions hold TVGN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$208261
Total value held
Buying
6 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $106460 | 18809 | +1475 | +8.51% |
| 2 | Goldman Sachs Group Inc | $86172 | 119963 | +14163 | +13.39% |
| 3 | Ubs Group Ag | $6130 | 1083 | +1083 | NEW BUY |
| 4 | Citigroup Inc | $4735 | 77212 | +61 | +0.08% |
| 5 | Jpmorgan Chase & Co | $2473 | 393 | -86 | -17.95% |
| 6 | Stonex Group Inc. | $1025 | 20252 | +20252 | NEW BUY |
| 7 | Royal Bank Of Canada | $1000 | 154 | +33 | +27.27% |
| 8 | Barclays Plc | $187 | 33 | -216 | -86.75% |
| 9 | Wells Fargo & Company/Mn | $79 | 14 | -297 | -95.50% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.